Pharm Ch47&48

noncancerous and not an immediate threat to life

leakage of an intravenously administered drug into the tissue space surrounding the blood vessel

the absence of cellular differentiation

a malignant neoplasm of blood-forming tissues

the term used for viruses that can cause cancer

the process by which cancer spreads from the original site of growth to a new and remote part of the body

antineoplatic drugs that are cytotoxic in any phase of the cellular growth cycle

a malignant neoplasm of the connective tissue arising in fibrous,fatty,muscular,synovial,cascular,or neural tissue

a permanent chande in cellular genetic material (DNA)

the lowest point reached by white blood cells after chemotherapy

ensure hydration up to 3000mL/day if not contraindicated

report a weight increase of 2 pounds or more in 24 hours or 5 pounds or more in a week

monitor for cough,dyspnea,and abnormal breath sounds

administering this drug helps to reduce hyperuricemia

report ringing or roaring in the ears or hearing loss

may be used in cases of anaphylactic reactions

administering this drug helps to decrease toxicities associated with doxorubicin

observe for ulcerations or oral mucous membrances

decreased levels of neutrophils may increase the risk for infection

increased bleeding and bruising may occur due to decreased platelet counts